首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21篇
  完全免费   4篇
  2018年   2篇
  2017年   3篇
  2015年   1篇
  2014年   3篇
  2013年   1篇
  2011年   5篇
  2010年   2篇
  2009年   1篇
  2007年   1篇
  2006年   1篇
  2003年   1篇
  2002年   2篇
  1997年   1篇
  1992年   1篇
排序方式: 共有25条查询结果,搜索用时 15 毫秒
1.
高效液相色谱法测定黄芪注射液中黄芪甲甙的含量   总被引:13,自引:0,他引:13  
本文报道用高效液相色谱法测定黄芪注射液中黄芪甲甙的含量。色谱柱为:NOVA-PAK C_(18)4μm(4.6mm×250mm);流动相:乙腈-0.1%磷酸(33:67),205nm检测,外标定量。结果表明,建立的方法完全适用于黄芪注射液中黄芪甲甙的含量测定。其方法快速、灵敏、重现性好。  相似文献
2.
黄芪注射液中对心脏正性肌力作用的成分分离与鉴定   总被引:13,自引:0,他引:13  
用豚鼠离体乳头肌的收缩力相对增强百分率为正性肌力作用的指标,研究了黄芪注射液及其各分离部分的活性,证明中性部分为有效部位,其正性肌力作用呈浓度依赖关系,并用放射配基受体结合分析法,证明其作用不是通过β-肾上腺素受体,也不依赖于儿茶酚胺的释放,活性部分的成分,通过柱层析分离出单体,并经波谱数据分析和标准样品直接对照,证明该单体为黄芪甙IV。  相似文献
3.
黄芪注射液的化学成分   总被引:11,自引:0,他引:11  
采用正、反相硅胶柱层析从黄芪注射液原液中分离纯化出 14个化合物 ,经波谱分析鉴定了它们的结构。其中 6个为异黄酮化合物 ,分别是芒柄花素 (1) ,毛蕊异黄酮 (2 ) ,6″ O 乙酰基芒柄花苷 (3) ,芒柄花苷 (7) ,红车轴草异黄酮 7 O β D 吡喃葡萄糖 (12 ) ,毛蕊异黄酮 7 O β D 吡喃葡萄糖 (13) ;1个紫檀烷化合物 ,结构为 9,10 二甲氧基紫檀烷 3 O β D吡喃葡萄糖 (4) ;1个异黄烷化合物 ,结构为 2′ 羟基 3′ ,4′ 二甲氧基异黄烷 7 O β D 吡喃葡萄糖 (6 ) ;另外 6个为黄芪皂苷类化合物 ,分别是乙酰黄芪皂苷Ⅰ(5 ) ,黄芪皂苷Ⅰ (8) ,异黄芪皂苷Ⅰ (9) ,异黄芪皂苷Ⅱ (10 ) ,黄芪皂苷Ⅱ (11)和黄芪甲苷 (14)。其中化合物 3系首次从黄芪属植物中分离得到。  相似文献
4.
黄芪叶中黄芪甲苷的含量测定   总被引:6,自引:0,他引:6  
目的 :测定黄芪叶中黄芪甲苷的含量 ,寻找提取黄芪甲苷的新药源。方法 :本实验以黄芪甲苷为标准品 ,采用薄层色谱—分光光度法测定黄芪叶中黄芪甲苷的含量。结果 :叶中的黄芪甲苷含量是根中的 2 .8倍。结论 :黄芪叶有潜在的开发价值  相似文献
5.
Zhang WD  Zhang C  Liu RH  Li HL  Zhang JT  Mao C  Moran S  Chen CL 《Life sciences》2006,79(8):808-815
Astragaloside IV, a natural product purified from the Chinese medical herb Astragalus membranaceus (Fisch) Bge, is now being developed as a cardioprotective agent for treating cardiovascular diseases. The purpose of the present study was to examine in vivo pharmacokinetics and tissue distribution in both rats and dogs by using an established high-performance liquid chromatography (HPLC) coupled with tandem mass spectrometry quantitative detection method. Astragaloside IV showed moderate to fast elimination; the elimination half-life of astragaloside IV was 98.1, 67.2 and 71.8 min in male rats, and 34.0, 66.9 and 131.6 min in female rats at doses of 0.75, 1.5 and 3.0 mg/kg, respectively. There was no significant difference in systemic clearance at three dose levels, suggesting that astragaloside IV may have linear pharmacokinetic characteristics in rats within the dose ranges tested. The highest concentration of astragaloside IV was detected in the lung and liver. However, limited distribution to the brain, indicates that astragaloside IV may have difficulty penetrating the blood brain barrier. In addition, only about 50% of the parent astragaloside IV was recovered in both urine and feces. These results indicate that there was about 83% astragaloside IV binding to plasma protein and that the binding to the plasma is linear at the concentration range of 250-1000 ng/ml. As in rats, astragaloside IV may have linear pharmacokinetic characteristics in dogs within the dose ranges tested. Astragaloside IV was slowly cleared via hepatic clearance with a systemic clearance (CL) of about 0.004 l/kg/min. Based on the favorable pharmacokinetic properties in both rats and dogs, astragaloside IV warrants further investigation for the prevention of cardiovascular diseases.  相似文献
6.
Parkinson's disease (PD) is caused by a progressive degeneration of dopaminergic neurons in the substantia nigra. Oxidative stress and neural degeneration are suggested to be involved in the pathogenesis of Parkinson's disease. In the present study, Astragaloside IV (AS-IV) extracted from the dried root of Astragalus membranaceus, a well-known Chinese medicine used for the treatment of neurodegenerative diseases, was investigated for its capacity to protect dopaminergic neurons in experimental Parkinson's disease. By examining the effect of AS-IV on 6-hydroxydopamine (6-OHDA)-induced loss of dopaminergic neurons in primary nigral culture, we found that AS-IV pretreatment significantly and dose-dependently attenuated 6-OHDA-induced loss of dopaminergic neurons. Neuronal fiber length studies showed that massive neuronal cell death with degenerated neurons was observed in those cultures incubated with 6-OHDA, whereas in AS-IV co-treatments most dopaminergic neurons were seen to be intact and sprouting. In flow cytometric analysis, AS-IV resulted in a marked and dose-dependent rescue in tyrosine hydrolase (TH)-immunopositive cells from 6-OHDA-induced degeneration of dopaminergic neurons. Double immunofluorescence revealed that AS-IV treatment alone at concentrations of 100 and 200 μM increased the level of TH and NOS (nitrite oxide synthase) immunoreactivities; however, the protective effect of AS-IV on TH and NOS immunopositive cells in 6-OHDA treated nigral cell cultures was only seen at a concentration of 100 μM. These findings show that AS-IV can protect dopaminergic neurons against 6-OHDA-induced degeneration. Besides the neuroprotective effect, AS-IV alone promoted neurite outgrowth and increased TH and NOS immunoreactive of dopaminergic neurons. The neuroprotective and neurosprouting effects of AS-IV are specific for dopaminergic neurons and it has therapeutic potential in the treatment of PD.  相似文献
7.
Hairy roots of Astragalus membranaceus were grown in bioreactors up to 30 l for 20 d. Cultures from a 30 l airlift bioreactor gave 11.5 g l dry wt with 1.4 mg g–1 astragaloside IV, similar to cultures from 250 ml and 1 l flasks, but greater than yields from a 10 l bioreactor (dry wt 9.4 g l–1, astragaloside IV 0.9 mg g–1). Polysaccharide yields were similar amongst the different bioreactors (range 25–32 mg g–1). The active constituent content of the cells approached that of plant extracts, indicating that large scale hairy root cultures of A. membranaceus has the potential to provide an alternative to plant crops without compromising yield or pharmacological potential.  相似文献
8.
黄芪甲苷后处理对乳鼠心肌细胞缺氧复氧损伤的作用研究   总被引:1,自引:0,他引:1  
目的:观察黄芪甲苷(AstragalosideⅣ,ASⅣ)后处理对缺氧复氧损伤(simulatedischemiareperfusioninjury,SVR0的SD乳鼠心肌细胞是否具有保护作用。方法:将乳鼠原代心肌细胞平均分为五组,即空白对照组(Control)、缺氧复氧处理组(SI/RI)、黄芪甲苷预处理(5,10、20μM)+SURI组(AsⅣ+SI/RI)。各组细胞经处理后,四氮唑溴盐比色法(MTT)检测各组细胞存活率;TUNEL染色法测定各组细胞凋亡率;SOD测试盒检测培养液中超氧化物歧化酶(SOD)含量,总嘌呤氧化酶(XOD)测试盒检测丙二醛(MDA)含量。Westernblot法检测各组细胞抗凋亡蛋白Bcl-2和促凋亡蛋白Caspase-3的表达。结果:与空白组相比,缺氧复氧损伤组细胞活力显著下降(P〈0.05),凋亡率显著上升(P〈0.05),其培养液中SOD水平显著降低(P〈0.05),MDA水平显著升高。而不同浓度AsⅣ后处理组的心肌细胞存活率显著上升,凋亡率显著下降,培养液中SOD水平显著上升,MDA水平显著下降(P〈0.05)。且呈浓度呈依赖性。Westernblot结果显示AsⅣ后处理组细胞中的Bcl-2表达明显上升,Caspase-3明显下降。结论:黄芪甲苷后处理对缺氧复氧诱导的乳鼠心肌细胞损伤具有显著的保护作用,能够显著上调抗凋亡蛋白Bcl-2的表达,下调促凋亡蛋白Caspase-3的表达。  相似文献
9.
Cycloastragenol (CAG), a bioactive triterpenoid sapogenin isolated from the Chinese herbal medicine Radix astragali, was reported to promote the phosphorylation of extracellular signal-regulated protein kinase (ERK). Here we investigated the effect of CAG on adipogenesis. The image-based Nile red staining analyses revealed that CAG dose dependently reduced cytoplasmic lipid droplet in 3T3-L1 adipocytes with the IC50 value of 13.0 μM. Meanwhile, cytotoxicity assay provided evidence that CAG was free of injury on HepG2 cells up to 60 μM. In addition, using calcium mobilization assay, we observed that CAG stimulated calcium influx in 3T3-L1 preadipocytes with a dose dependent trend, the EC50 value was determined as 21.9 μM. There were proofs that elevated intracellular calcium played a vital role in suppressing adipocyte differentiation. The current findings demonstrated that CAG was a potential therapeutic candidate for alleviating obesity and hyperlipidemia.  相似文献
10.
目的:探讨黄芪甲苷对人骨髓间充质干细胞体外增殖及细胞因子表达的影响。方法:采用Percoll密度离心法和贴壁法分离纯化hBMSC;流式细胞术检测hBMSC表面标志;MTT法检测不同浓度黄芪甲苷干预72h后hBMSC的增殖情况;Real-timePCR法检测经黄芪甲苷干预后hBMSC对SCF、VEGF、SDF-1、GM-CSFmRNA的表达水平。结果:成功分离培养出laBMSC;不同浓度(20、40、80、160、320mg/mL)的黄芪甲苷可促进hBMSC增殖(P〈0.05),其中160mg/mL组促增殖最明显;黄芪甲苷可促进hBMSC对SCF、VEGF、SDF-1mRNA的表达,而GM—CSFmRNA表达无明显变化。结论:黄芪甲苷可促进hBMSC体外增殖,可能与其促进hBMSC对SCF、VEGF、SDF-1mRNA表达有关。  相似文献
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号